Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

New Program Bolsters Healthcare Startup Ecosystem in Orange County and Southern California


News Image

Tech Coast Angels (TCA) and the Octane LaunchPad SBDC (Small Business Development Center) have established a new joint program, called Orange County Healthcare Innovation Table (OC HiT).

The joint program, referred to as Medical Mondays, was created to advance the development, implementation, funding, and commercialization efforts of healthcare startups, primarily in Orange County and Southern California. This collaboration aims to support and guide startups in being better positioned scientifically, technically, clinically, and financially to enter the marketplace.

OC HiT is collaborating with two renowned healthcare systems: CHOC Children’s Hospital of Orange County (CHOC) through its Research Institute and Hoag, which provide expertise and support for clinical development process.

Consultants at Octane’s LaunchPad SBDC, together with TCA, Hoag and CHOC, assess and validate startups’ technologies and commercialization roadmaps to more quickly secure funding and clinical adoption.

OC HiT Medical Mondays were successfully piloted in 2022, engaging 80 startups. The program resulted in 30 startups being matched and introduced to a clinical or hospital partner; seven startups were offered clinical collaborations, and 22 were invited to apply to at least one of the TCA networks.

Ideal candidates for Medical Mondays will have an established team, are beyond the ideation stage, and are either working on or have completed a proof of concept or early animal trials. The program will be fluid and adapt to each startup’s particular needs and circumstances. Candidates may be from outside of California and the U.S., although these candidates should have plans for a U.S. operation, ideally in or planned to be in the Southern California region.

The LaunchPad SBDC team will review start-up applications, pre-qualify them for joint reviews, and provide LaunchPad SBDC consultants to help with business strategy, planning, operations, funding, and development of a pitch deck if a startup doesn’t currently have one. Startups also will have the option to participate in Octane programs and conferences.

The Hoag and CHOC team will provide feedback by assessing the clinical problem and need, prototype application and requirements as well as regulatory strategy. The team’s goal is to ensure that startup innovations are attractive to hospitals and physician groups as future customers. The team will be able to potentially engage Hoag and CHOC resources, research and clinicians who can serve as subject matter experts.

The TCA team will focus on investability and also be available to review applications submitted by the company as well as potentially be a source of funding through one of the TCA networks. TCA experts may advise on the technology, market size, share, growth, and financial projections.

For more information or to participate, please contact Laura Beken, laura.beken@techcoastangels.com

About TCA

Since its inception in 1997, Tech Coast Angels (TCA) has invested more than $261 million in more than 520 companies and has helped attract more than $1.7 billion in additional capital/follow-on rounds. The Tech Coast Angels network includes TCA Los Angeles, TCA Orange County, TCA Inland Empire, and licensees including Pasadena Angels and MEDA Angels. One of the largest and most active angel investor groups in the nation, TCA and its affiliate member networks include more than 400 members, and are a leading source of funding for seed-stage and early-stage companies. TCA members are founders and business leaders, all of whom are accredited investors with extensive knowledge in the investment process and world-class business practices. That real-world experience allows TCA members to provide companies with benefits beyond capital: counsel, mentoring, and access to an extensive network of investors and other resources. http://www.techcoastangels.com

About LaunchPad SBDC

LaunchPad SBDC is a non-profit and grant-funded late-seed/early VC business startup accelerator focusing on tech, medtech, aesthetic innovation, ophthalmology, cardiology and climate tech. Startups work with LaunchPad SBDC consultants to develop and accelerate their capital funding strategy

About Hoag R&D

At Hoag, the Center for Research and Education is conducting several hundred clinical trials with governmental (e.g., NIH) and biotech industry sponsors, including Phase 1 cancer and Alzheimers therapeutics. Early stage companies in the pharma, device, software, and AI space find Hoag’s clinical research and development capabilities a seamless and highly efficient way of translating new technology to the clinical bedside stage. Hoag understands the critical importance in allowing our community’s patients access to the most novel therapies once safety is assured through the FDA approval process, and then documenting the efficacy of such innovation in a real world clinical setting, where continuous improvement of such advancements can occur to benefit all of healthcare.

About Hoag

Hoag is a nonprofit, regional health care delivery system in Orange County, California. Delivering world-class, comprehensive, personalized care, Hoag consists of 1,800 top physicians, 15 urgent care facilities, 10 health & wellness centers, and two award-winning hospitals. Hoag offers a comprehensive blend of health care services that includes six institutes providing specialized services in the following areas: cancer, digestive health, heart and vascular, neurosciences, women’s health, and orthopedics through Hoag’s affiliate, Hoag Orthopedic Institute, which consists of an orthopedic hospital and four ambulatory surgical centers. Hoag is the highest ranked hospital in Orange County by U.S. News & World Report and the only OC hospital ranked in the Top 10 in California, as well as a designated Magnet® hospital by the American Nurses Credentialing Center (ANCC). For more information, visit hoag.org.

About CHOC Research

At CHOC, we know that research saves lives. That’s why our Research Institute has more than 500 research studies in more than 30 specialties to provide your child with access to leading-edge treatments. Our scientists translate the latest advances in molecular profiling, including whole genome sequencing, to meet the individual needs of our patients at every stage of their young lives —from infancy through adolescence. We conduct research directly with children and adolescents in a facility devoted exclusively to the care, quality of life, rights, and safety of children of all ages.

About Children’s Hospital of Orange County

Children’s Hospital of Orange County (CHOC), a pediatric healthcare system based in Orange County, California, is committed to being a leading destination for children’s health by providing exceptional and innovative care. CHOC’s growing community includes two state-of-the-art hospitals in Orange and Mission Viejo and a regional network of primary and specialty care clinics serving children and families in four counties. CHOC offers several clinical programs of excellence providing the highest levels of care for the most serious pediatric illnesses and injuries, physical and mental. CHOC’s research and innovation institutes are focused on translating real patient needs into real-world treatments so every child can live the healthiest and happiest life possible.

Plastic Ingenuity Shares Top 5 Initiatives in Sustainable Packaging Solutions


Woman holding Plastic Ingenuity 2023 Circularity Report

Plastic Ingenuity has identified five sustainability initiatives that reflect evolving priorities in the healthcare, food and CPG industries.

We hope to inspire brands to adopt packaging that is as sustainable as possible without impeding its function, which is to preserve and protect its contents.

Plastic Ingenuity, the largest custom thermoformer in North America, reveals in its new report key sustainability drivers propelling the packaging industry to support a more circular economy. Plastic has an indispensable role in the marketplace but that is often overlooked due to prevailing misconceptions about its use and benefits.

“Most people don’t consider how the convenience, safety and affordability of the products they use daily are made possible by plastic,” said Dan Kuehn, President and CEO of Plastic Ingenuity. “Plastic should absolutely be part of the circular economy. That’s something that we, and the wider packaging industry, are trying to address.”

Plastic Ingenuity has published its second annual Circularity Report to highlight challenges, opportunities and successes from the past year, including valued insights gleaned from sustainability and packaging professionals. Based on these conversations, Plastic Ingenuity has identified five sustainability initiatives that reflect evolving priorities in the healthcare, food and consumer goods (CPG) industries, and that will drive innovation and market growth in the years ahead.

1. New influences advancing sustainability initiatives.

Organizations across industries are facing heightened priority on sustainability efforts, fueled by a confluence of forces. Specifically, the number of sustainability-minded consumers is increasing, causing a shift in expectations, especially among younger demographics. The scale and buying power of large retailers and group purchasing organizations are a major influence on CPG and healthcare organizations, respectively. Additionally, the leadership of non-governmental organizations (NGOs) and legislative policy are driving progress. Another catalyst, newly cited in 2022, is investor influence. As one stakeholder noted, “Sustainability goals are now factored into executive compensation. This provides accountability and influences action from the top down.”[1]

2. Expanded understanding of circularity in packaging.

Many organizations recognize that transitioning to a circular economy is necessary to achieve responsible consumption goals. According to Plastic Ingenuity’s 2022 stakeholder study, 64% of respondents said their organizations are focused on maximizing post-consumer recycled (PCR) content in their packaging to enhance circularity.[1] Not only does using PCR help minimize material waste, it also significantly lowers the carbon footprint of a package. Moreover, the demand for PCR stimulates the economic incentives that support recycling industry operations. This is critical, as collection and recovery need to expand to meet accelerating demand for recycled materials.

3. Increasing need to recover all packaging types.

Improving recovery rates of all packaging types is essential to unlock true circularity in packaging. In fact, the goal to increase recovery was cited by 92% of surveyed stakeholders, and 67% indicated it’s a top priority.[1] Four tactics can help improve recovery rates, including making packages from recyclable materials, designing packages for recovery, increasing package recovery in practice, and exploring closed-loop recycling. Notably, closed-loop recycling is an option when traditional recycling systems are unavailable, such as within the highly regulated healthcare industry.

4. Innovative technologies improving recycling capabilities.

Advanced recycling techniques and mass balance systems have the potential to unlock new opportunities for using PCR materials in more types of packaging, including healthcare applications. Advanced recycling, also called chemical recycling, is a suite of novel recycling techniques that focuses on hard-to-recycle materials,[2] while a mass balance system is a chain-of-custody protocol that tracks recycled content. Plastic Ingenuity has attained pending ISCC PLUS certification, verifying accuracy of its manufacturing processes through third-party audits.[3]

5. Design enhancements supporting waste reduction.

Design optimization is enabling greater packaging circularity. The Association of Plastics Recyclers Design Guides, HPRC’s Design Guidance for Healthcare Plastics Recycling and other resources help create packages designed for recovery. Additionally, packaging systems are being evaluated holistically to determine where reductions can be made. A minimalist approach can help reduce weight and material usage, increasing shipping and other downstream efficiencies. As one stakeholder noted, “A little bit of packaging reduction goes a long way.”[1]

Each of these initiatives are explored in detail in Plastic Ingenuity’s 2023 Circularity Report. Furthermore, for every download before Dec. 31, 2023, Plastic Ingenuity will donate $5 to Project Drawdown. Project Drawdown’s mission is for the world to reach “drawdown” – the point in the future when levels of greenhouse gases in the atmosphere stop climbing and start to steadily decline, thereby stopping catastrophic climate change – as quickly, safely and equitably as possible.

“By sharing this report, we hope to inspire brands in the food, healthcare and CPG industries to adopt packaging that is as sustainable as possible without impeding its function, which is to preserve and protect its contents,” said Zach Muscato, Corporate Sustainability Manager at Plastic Ingenuity. “We’re also using these insights to inform our circularity and sustainability capabilities at Plastic Ingenuity, ensuring our progress adds value for our customers.”

Visit http://plasticingenuity.com to access the report.

[1] Plastic Ingenuity, Packaging Sustainability Stakeholder Study, 2022

[2] Closed Loop Partners, Transitioning to a Circular System for Plastics: Assessing Molecular Recycling Technologies in the United States and Canada, 2021

[3] International Sustainability & Carbon Certification

About Plastic Ingenuity

With seven strategic locations, Plastic Ingenuity is one of the largest custom thermoformers in North America. Its experience, global reach, and genuine dedication to customers allows the company to bring clients’ packaging vision to life, scale the product, and create a partnership that lasts beyond the product’s lifecycle. Specializing in food, healthcare and consumer goods packaging, Plastic Ingenuity offers a range of services to support customers sustainability and circularity goals, including sustainable packaging assessment, sustainability roadmaps, recyclability consulting, life-cycle assessment and take-back programs. For more information, visit http://www.plasticingenuity.com.

Griswold Celebrates National Caregivers Day With Plans to Award $100,000 in Nationwide Scholarships to Caregivers this Year


Griswold, the fast-growing non-medical home care franchise with over 170 locations, recently announced the opening of its 2023 National Caregiver Scholarship Program in partnership with its nonprofit organization, the Jean Griswold Foundation, for the second year. The program aims to award $100,000 in scholarships to qualified caregivers across the country, kicking off on National Caregivers Day on February 17, 2023.

“This program is designed for family caregivers, professional caregivers or anyone interested in pursuing a career in the care industry,” said Jean Griswold Foundation Acting Director, Sarah Latini. “Our mission is to support caregivers everywhere by providing scholarships that are directed to training, certification and degree enhancement in their field. Through these scholarships, we hope to impact the lives of the caregivers, as well as the families and the clients they serve now and in the future as they advance in their careers.”

The Jean Griswold Foundation was founded in 2010 as a private nonprofit to support caregiving organizations in times of hardship, and was named after Dr. Jean Griswold to help carry on her legacy. Until 2021, funds raised through private donors, corporations, franchisees, and employees had been primarily awarded to individuals and programs dedicated to senior care, but the intention was always to offer a way for caregivers to improve their ability to pursue care-related work. When the COVID-19 pandemic hit and the need for home health became more pressing than ever, Latini says the foundation decided to reorganize their approach to fully focus on caregivers.

“We knew that caregivers were holding families and clients together following the pandemic, so we redesigned our mission to specifically help them pursue their career dreams through scholarships,” said Latini. “Since starting the scholarship program last year, we are already making leaps and bounds in achieving our mission.”

In 2022, the Jean Griswold Foundation awarded $24,000 in scholarships to 12 caregivers from across the country with amazing stories of perseverance and fortitude. This year, that number is jumping to a whopping $100,000 because of how successful the fundraising program was last year. The denominations allocated to each caregiver will range from $2,000 to $10,000 depending on the scholarship.

One recipient of the 2022 scholarships, Jessica Perez, was acknowledged for putting others first in her commitment to helping others. Perez is the oldest sibling in her family and grew up taking care of her siblings. As a result, her schooling needs were put on the back burner to help provide for her family. But through that care, she found her passion in healthcare and helping those in need. She also finds inspiration from her husband who is paralyzed and confined to a wheelchair, something she says gives personal meaning to her career.

“Nothing ever happened to me like this. I am always taking care of everybody, and I want to do more. What else can I do, what else can I learn?” said Perez. Since receiving her scholarship in July 2022, she has graduated with her Certified Nurse Assistant (CNA) license.

“When Jean Griswold started this company in 1982, she made sure that she was able to give back,” said Chair of the Jean Griswold Foundation and Griswold franchisee Maryanne Murray. “I am really happy to be able to continue that philanthropy today. Our scholarship program is improving the lives of Griswold caregivers and all caregivers in general. Of the 12 we were able to support last year, for example, many of them have already achieved certification or taken advancements in their careers. That also helps us serve our clients better and impact the community at large. This year, we have the chance to do even more, all thanks to the generous donors who are making contributions to this cause.”

And the need for caregiver support is more important than ever, Latini says. “as we see the senior population growing, more people need in-home care,” she said. “Caregivers provide that glue to make sure clients and patients are receiving the care they need, staying on track with their home experience and keeping them out of health care facilities. That is more critical than ever.”

Additionally, Murray says these kinds of caregiver-focused initiatives help further position Griswold franchisees as employers-of-choice in the senior care industry. “The scholarships will set us apart from other home care agencies and will help us recruit caregivers, too,” she adds. “It’s also a good way to distinguish ourselves during a time of caregiver shortages and so much competition. We attract remarkable caregivers who seem to enjoy our culture, and we definitely enjoy what they’re bringing to the table. We have fabulous caregivers on our teams, and they’re really the lifeblood of our industry.”

Those interested in applying for the 2023 National Caregiver Scholarship Program can visit the Jean Griswold Foundation’s Scholarship Program page and fill out the form between February 17, 2023 and April 26, 2023. Both applicants and sponsors will need to fill in their designated information. The first round of winners will be announced on July 30th, Jean Griswold’s birthday.

“At the end of the day, this is all about honoring those people on the frontline of home care,” said Latini. “Those heroes don’t generally receive enough credit for the wonderful work they do and the sacrifices they make everyday, and we are excited to be giving back and recognizing that commitment at the same time.”

On being a care provider with Griswold, Genene Brown, a Caregiver who just returned to her Griswold roots after taking care of her parents for some time, agrees that those in the client-facing roles are truly dedicated to their practice. “You have to have patience, and you have to care about what you do,” says Brown. “You get so attached to your clients and really learn something new every day.”

Franchise opportunities range from $95,850 to $174,100 including a $49,500 franchise fee. For more information about franchising with Griswold, please visit https://www.griswoldhomecare.com/franchising/investment-info/.

NCPDP Announces Robin Farmanfarmaian as Keynote Speaker for its 2023 Annual Technology & Business Conference, “The Great Race to Close Gaps in Care”


National Council for Prescription Drug Programs (NCPDP)

NCPDP announced today Robin Farmanfarmaian, speaker, author, and tech entrepreneur, will give an important closing keynote address about the future of healthcare, technology, and patient empowerment at NCPDP’s 2023 Annual Technology & Business Conference, “The Great Race to Close Gaps in Care”, May 8-10, 2023, at the Westin Kierland Resort & Spa in Scottsdale, Arizona. NCPDP’s national annual conference draws more than 700 attendees from across the healthcare industry, including technical, business, and executive representatives from health plans, pharmacy benefit managers, retail and independent pharmacies, specialty pharmacies, long-term care providers, healthcare consultants, technology vendors, pharmaceutical manufacturers, wholesale drug distributors, database management organizations and others.

“As a patient who has a particularly difficult and unique story to tell, Robin Farmanfarmaian embodies what it means to take charge of one’s own health with sheer determination and force of will,” says Lee Ann Stember, President & CEO of NCPDP. “She offers an inspiring picture of the future of healthcare, one that empowers patients and explores new technologies to expand our knowledge and capabilities beyond what we ever thought possible. Her keynote address is sure to resonate with our conference attendees who are passionate about patient empowerment, and how technology and interoperability will shape and support innovations in healthcare and healthcare delivery to close gaps in care.”

Robin Farmanfarmaian, who lives, breathes, and works on the cutting edge of all things medical technology, has an incredible story to share. After overcoming years of suffering due to a misdiagnosed illness, undergoing dozens of painful and extreme treatments and surgeries culminating in the removal of her large intestine, and facing a permanent spinal morphine pump at 26 years old, Robin took her health into her own hands and fought to gain a corrected diagnosis. Overnight she saw a complete shift in her well-being and quality of life, a shift which launched her passion for improving patient care and healthcare delivery.

As an entrepreneur in Silicon Valley, Robin works with companies on ground-breaking healthcare technology, including more than 20 early-stage startups focused on state-of-the-art biotechnology and cutting-edge technology for pharmacy, medical devices, and digital health. She co-founded five startups, including the Organ Preservation Alliance, where she worked with the White House and Department of Defense (DoD) to fund scientists in cryopreservation and tissue engineering for organ transplants. Robin has worked on multiple early-stage pharmaceuticals, including small molecules found through AI for drug discovery on the p53 and AhR pathways, inhaled insulin, and a vaccine. Robin serves in an advisory role to Luxsonic, a radiology reading room in VR and Alacrity Care, which provides remote patient monitoring and data analytics for oncology.

As a professional speaker, Robin has inspired more than 180 audiences in 15 countries with her incredible journey of self-healing and is the author of four books, including, “The Patient as CEO: How Technology Empowers the Healthcare Consumer” and her latest, “How AI Can Democratize Healthcare: The Rise in Digital Care” with Michael Ferro.

NCPDP’s 2023 Annual Technology & Business Conference is open to all healthcare industry stakeholders. To register for the conference visit https://ncpdp.org/ac/register.aspx. The Early Bird rate is available through February 27, 2023.

The complimentary media registration form can be downloaded here.

For real-time updates before and during the event, follow us at http://twitter.com/ncpdp or join the discussion using NCPDP’s 2023 Annual Technology & Business Conference hashtag: #NCPDP23.

Journalists: Click here to download a photo of Robin Farmanfarmaian.

About NCPDP

The National Council for Prescription Drug Programs (NCPDP) is a not-for-profit American National Standards Institute (ANSI) Accredited Standards Developer (ASD) consisting of more than 1,500 members representing entities including, but not limited to, claims processors, data management and analysis vendors, federal and state government agencies, insurers, intermediaries, pharmaceutical manufacturers, pharmacies, pharmacy benefit managers, professional services organizations, software and system vendors and other parties interested in electronic standardization within the pharmacy services sector of the healthcare industry. NCPDP provides a forum wherein our diverse membership can develop business solutions, including ANSI-accredited standards and guidance for promoting information exchanges related to medications, supplies, and services within the healthcare system.

NCPDP has been named in federal legislation, including HIPAA, MMA, and HITECH. NCPDP members have created standards such as the Telecommunication Standard and Batch Standard, the SCRIPT Standard for ePrescribing, the Manufacturers Rebate Standard, and more to improve communication within the pharmacy industry. Our data products include dataQ®, a robust database of information on more than 80,000 pharmacies, resQ™, an industry pharmacy credentialing resource, and HCIdea®, an innovative prescriber database that provides continually updated information on more than 2.5 million prescribers. NCPDP’s RxReconn® is a legislative tracking product for real-time monitoring of pharmacy-related state and national legislative and regulatory activity. For more information about NCPDP Standards, Data Services, Products, Educational Programs, and Work Group meetings, go online at http://www.ncpdp.org or call 480.477.1000.

###

Share article on social media or email:



Pleora Scores a 10 with New High-Performance GigE Vision Embedded Interface


Pleora Technologies today introduced a new embedded interface that seamlessly transmits low latency GigE Vision video and data at 10 Gbps over flexible Ethernet cabling. Lead customers are now designing the iPORT NTx-Deca embedded interface into X-ray flat panel detectors (FPDs) for medical, dental, and industrial applications, contact image sensors, and high-performance machine vision cameras.

“We are expanding our portfolio of GigE Vision embedded interfaces to provide imaging device manufacturers with a flexible range of 1 to 10 Gbps solutions that reduce development time and costs while simplifying system integration,” said Jonathan Hou, President, Pleora Technologies. “With our comprehensive embedded interface portfolio built on two decades of imaging expertise, developers can support a range of bandwidth and performance requirements with a common design approach that is scalable across multiple devices and applications.”

Compared with competing approaches that consume design time and dollars and divert development teams from critical system performance features, the iPORT NTx-Deca provides an off-the-shelf GigE Vision standard compliant solution that ensures interoperability in multi-vendor systems. Connect your sensor to the iPORT NTx-Deca, and the off-the-shelf solution seamlessly handles 10 Gbps video and data transport over flexible Copper Cat 6A Ethernet cabling for distances up to 100 meters. GigE Vision 2.0 compliance streamlines interoperability in multi-vendor imaging systems and applications.

The iPORT NTx-Deca integrates unique Image Management Database features to enhance system reliability. For high-reliability applications, such as medical and dental imaging, end-users can store video frames with associated metadata for patient identification, video replay, and traceability. In the event of a power or network failure, image management allows a user to retrieve data to ensure continuous and reliable inspection. The embedded interface supports IEEE 1588 Precision Time Protocol (PTP) to synchronize image capture and imaging system elements, with programmable logic controller (PLC) integration to seamlessly connect to and control critical manufacturing or inspection system components.

The iPORT NTx-Deca is supported by Pleora’s eBUS Software Development Kit, the industry leading choice for image capture, display, and transmission in thousands of mission-critical automation, security and defense, and medical applications. For full product details, including data sheets and technical resources, visit https://www.pleora.com/machine-vision-automation/iport-ntx-deca/.

Share article on social media or email:

Alucio™ Releases New Beacon Hub Feature to Enable Ongoing KOL Engagement


News Image

“Our new Beacon Hub feature is a convenient and creative way to extend scientific engagement well beyond the specific meeting interaction,” explained Tom O’Connell, Co-Founder & COO. “We are very excited about this latest enhancement to our Beacon platform to help address a clear customer need.”

Alucio™, a fast-growing provider of cloud-based software for the life sciences industry, today announced an update to its Beacon scientific exchange platform to better serve Healthcare Professionals (HCPs) and life science companies in their scientific discussions. This unique Beacon Hub feature will provide HCPs and Medical Science Liaisons (MSLs) with the ability to collaborate, engage, and exchange information, in a shared, secure online space outside of actual meetings. This convenient option allows for follow-on exploration and communication exchanges on shared scientific topics which can build trust and deepen relationships.

Beacon is a modern content activation and HCP engagement platform built specifically for Medical Science Liaisons (MSLs), Medical Affairs professionals and Market Access teams.

This new personalized communication feature offers multiple ways for MSLs to facilitate permission-based interactions with HCPs after a meeting. These include providing read-only scientific documents or presentations, collaborating on shared action items, posting follow up on flagged topics from previous exchanges, sharing files, and accessing relevant journal articles or other web resources. This allows HCPs and MSLs to continue to engage each other asynchronously.

Beacon Hub is configurable to reflect life science company branding, compliance, and data synch requirements and complements internal CRM systems. In addition, as a return destination for the HCPs, Medical Information support can also be seamlessly integrated to respond to new inquiries that may arise.

All interactions on Beacon Hub are tracked and synthesized to help Medical Affairs make better decisions regarding digital engagement strategies, scientific content development efforts, and future HCP collaborations. The feature can also be used very effectively by Market Access teams and field-based Account Directors to address similar needs with their key customers.

“Life science companies are continually looking for ways to provide value to their KOLs and deepen relationships. Our new Beacon Hub feature is a convenient and creative way to extend scientific engagement well beyond the specific meeting interaction,” explained Tom O’Connell, Co-Founder & COO. “We are very excited about this latest enhancement to our Beacon platform to help address a clear customer need.”

About Alucio:

Alucio is dedicated to the development of innovative software applications specifically for the life sciences industry. Alucio’s flagship product, Beacon, is a modern, cloud-based scientific exchange platform that enhances scientific dialogue and engagement between life science companies and healthcare professionals. For more information, please visit the company’s website at http://www.alucio.io or contact Lisa Amin at lamin@alucio.io (925) 788-3533.

Share article on social media or email:

McLaren Health Care’s New Greater Lansing Hospital Chooses MEDI+SIGN for Enhanced Patient Experience


McLaren Greater Lansing Hospital

McLaren Greater Lansing Hospital

“We are devoted to providing our patients with the absolute best quality of care possible… keeping them informed is vital; and that’s exactly what MEDI+SIGN helps us do.” – Amanda Lampron, Interim Chief Nursing Officer and Director of Patient Care Services, McLaren Greater Lansing

McLaren Greater Lansing’s new $600 million hospital opened in March 2022, combining the operations from McLaren’s Greenlawn and Pennsylvania Avenue campuses.

The McLaren Greater Lansing Hospital serves the community with the highest quality of care, utilizing the newest technologies in all areas of the hospital, from radiology and diagnostics to operating rooms and patient-facing communications. With the Greater Lansing Hospital, McLaren Health Care continues to integrate MEDI+SIGN as the corporate standard for digital patient room whiteboards and digital door displays across their 15-hospital network covering Michigan and Ohio.

The new 750,000-square-foot health care campus is located at the MSU Foundation’s University Corporate Research Park. The main hospital boasts a nine-story tower with a 240-bed, state-of-the-art hospital, 17 operating rooms, three catheterization labs, an electrophysiology lab, a heart station, a 50-bed emergency department, an endoscopy suite, a radiology suite, and all public and support spaces. This new hospital contains all of the newest clinical equipment and technology available, making it one of the safest and highest-quality acute care hospitals in the Midwest. This comprehensive health care campus is home to over 1,000 physicians, researchers, educators, and other members of the academic and medical team.

“We have redesigned the traditional hospital and ambulatory care settings to build the safest, most efficient health care campus in the world,” says Kirk Ray, President and Chief Executive Officer of McLaren Greater Lansing. “This project isn’t just about bricks and mortar; this is about reinventing health care delivery. The campus and the actual processes of care were designed by our nationally recognized researchers, clinicians, nurses, technicians, physicians, the people who support the delivery of health care, and most importantly, our patients.”

“We are devoted to providing our patients with the absolute best quality of care possible,” says Amanda Lampron, Interim Chief Nursing Officer and Director of Patient Care Services at McLaren Greater Lansing. “The unique way that MEDI+SIGN allows us to address communication challenges creates an enhanced patient experience, while also allowing the family to participate in that process. This helps us present our patients with a comprehensive plan for the day, including input from Respiratory Therapy, Occupational Therapy, and others. All while utilizing our staff’s existing workflows, without adding anything new, keeping the focus on the bedside. Our patients are our top priority, and keeping them informed is vital; and that’s exactly what MEDI+SIGN helps us do.”

This new, modern hospital was built with efficiency and the patient experience in mind. The hospital boasts a bright, open environment with a large lobby, gift shop, cafeteria, open outdoor spaces and walking trails, and private patient rooms with beautiful views.

“It’s tough when you’re going through something that brings you or a loved one to the hospital. We want to make it as painless as we can, knowing it’s a tough time,” said Austin Holcomb, program manager on the construction project. “We’re really trying to keep the patient experience in mind as we’ve designed this facility.”

“As part of the focus on patient experience, Greater Lansing Hospital has installed MEDI+SIGN, fully integrated in-room displays, into the patient rooms on all floors, including Med Surg and ICU,” says David Linetsky, Founder/CEO of MEDI+SIGN. “The MEDI+SIGN electronic patient room whiteboards replace the traditional dry-erase boards in the patient rooms, to focus on communication enhancements while substantially reducing the staff workload.”

The field-proven MEDI+SIGN solution is fully integrated with Cerner®, McLaren’s electronic medical record (EMR), as well as their smart communications platform Vocera, to display the patient’s real-time health care data to clinicians, patients, and their families.

About McLaren Greater Lansing

McLaren Greater Lansing (formerly Ingham Regional Medical Center), a teaching hospital located in Lansing, Michigan, is a subsidiary of the McLaren Health Care Corporation. It is affiliated with both the College of Human Medicine and the College of Osteopathic Medicine of Michigan State University.

McLaren and Michigan State University have enjoyed a long and productive relationship on medical education, clinical care, and research. As a teaching site of Michigan State University, McLaren Greater Lansing annually trains more than 150 residents, fellows, and medical students from both the College of Human Medicine and College of Osteopathic Medicine.

McLaren and MSU researchers are already partnering on 36 active research protocols to better understand and treat breast cancer, prostate cancer, colon cancer, heart attacks, heart failure, COPD, strokes, and more. McLaren Orthopedic Hospital is also home to the MSU Center for Orthopedic Research.

Many attending and resident physicians serve in MSU faculty appointments, actively instructing and mentoring Michigan State University medical students. More than 165 MSU physicians are on the McLaren Greater Lansing medical staff, and more than 50 MSU College of Nursing students trained at the hospital in 2016-2017.

Alongside the new hospital, there will also be a cancer center and ambulatory care center among other health care facilities to promote research, health care services, and educational opportunities within the community. Learn more about McLaren Greater Lansing’s New Campus.

About MEDI+SIGN

MEDI+SIGN is a game-changing communication tool used by hospitals that are pursuing the creation, improvement, and sustainability of their quality and safety goals. Driven and perfected by evidence-based outcomes, MEDI+SIGN deploys strategies tailored to the hospital’s specific needs and existing workflows. This unique approach allows hospitals to experience quality and safety transformations without negatively impacting the day-to-day workflow of staff. MEDI+SIGN is the first and only patient-facing technology in its class that requires zero effort from clinical staff while reinvesting time back to the bedside. With patient experience and complex psychology at the epicenter of this technology, patients are kept informed, satisfied, and safe. Beyond patient experience, MEDI+SIGN focuses on improving HCAHPS and increasing patient safety by preventing falls as well as other sentinel events related to HAC, among other CMS programs. To experience these results for yourself, visit MEDI+SIGN Displays.

*Cerner is a registered trademark of Cerner Corporation

*Vocera is a registered trademark of Vocera Communications

MEDI+SIGN is a registered trademark. © 2023 MEDI+SIGN® All Rights Reserved

New Research Shows Opportunity for Healthcare Brands to Connect with LGBTQ+ Individuals


“Our research aims to help our clients and the greater health industry to understand how to serve this community in a way that is respectful and valuable,” said Dr. Susan Dorfman, CEO and President, CMI Media Group, and executive sponsor of the agency’s ERG PLUS+.

LGBTQ+ individuals want to hear from healthcare brands year-round – not only during Pride Month – and across a wide range of health concerns, as well as see LGBTQ+ aligned values at a corporate level. These are the major findings from a new study released by healthcare communications specialist CMI Media Group, a WPP company (NYSE: WPP), conducted in partnership with LGBTQ+ research firm Community Marketing & Insights.

There is opportunity for life sciences manufacturers to not only build connections, but also to redefine health among the LGBTQ+ community. Taking a whole-person approach to think about health in terms of physical, mental, and emotional well-being is critical, as members of this community are met with particular adversity and challenges that affect them in ways unfamiliar—and likely unrelatable—to others.    

As one example, while mental health remains a top priority, and the majority of those polled experienced anxiety, low use of medication and mental health services suggest barriers to care that healthcare brands need to consider before engaging with LGBTQ+ individuals.

“The LGBTQ+ community is incredibly diverse and deserving of personalized information and support from healthcare brands,” noted Dr. Susan Dorfman, CEO and President, CMI Media Group, and executive sponsor of the agency’s ERG PLUS+. “Our research aims to help our clients and the greater health industry to understand how to serve this community in a way that is respectful and valuable.”

Pharma and life sciences clients can request a free copy of the research at this link.

The research was conducted in partnership with Community Marketing & Insights. Community Marketing & Insights has built a proprietary research panel of 50,000+ diverse LGBTQ+ community members through partnerships with more than 300 LGBTQ+ publications, websites, blogs, social media, influencers, apps, events, and organizations. Many of their panel members have been active for over two decades. This is the third year the companies have partnered on this research.

CMI Media Group’s Audience Intelligence practice holistically connects audience strategy, marketing/ad research, social intelligence, and data insights further enabling always-on intelligence that drives dynamic content, media-mix optimization and deeper engagements. With a focus on driving clients towards where innovation and data intersect, this forward-thinking mentality will continue to position the company as the leader in precisely human insight and activation.

CMI Media Group’s Inclusive Media Center of Excellence, which is dedicated to healthcare, supported this research. The Inclusive Media COE is a catalyst for change, strategically driving investment in underserved audiences, providing equitable coverage and access to information to support their healthcare journeys.

Also supporting this research was CMI Media Group’s Employee Resource Group (ERG) PLUS+, which exists to educate and raise awareness for the LGBTQ+ community. It is a safe space for dialogue that builds respect, empathy, and inclusion for our organization, as well as forming and expanding partnerships and giving back through community outreach. PLUS+ stands for Promoting LGBTQ+ Understanding and Solidarity.

About CMI Media Group

CMI Media Group, a WPP company (NYSE: WPP, http://www.wpp.com), is a full-service global media agency focused solely on health, wellness, and pharmaceutical marketing. CMI Media Group’s core offerings include Audience Strategy, Planning, Development, and Insights; Data and Analytics; Buying and Investment; and Direct Response and Customer Experience. As the leading media resource for the world’s top healthcare companies, CMI Media Group brings together leading technology, data, and talent to deliver seamless capabilities for clients. CMI Media Group has been recognized as a leader in DE&I, talent retention and employee development as well as one of the industry’s best places to work. To apply for a position within our teams visit https://cmimediagroup.com/careers

Share article on social media or email:

Mark Cuban Cost Plus Drug Company Teams Up with CaringWire


“People need actual health care, not just insurance. This relationship unifies critical components to make that a reality,” said Alex Oshmyansky, CEO of Mark Cuban Cost Plus Drug Company

Mark Cuban Cost Plus Drug Company, PBC (Cost Plus Drugs) and CaringWire have announced a collaboration that aims to make healthcare more accessible and transparent. The collaboration combines CaringWire’s personalized virtual care platform and Cost Plus Drugs’ transparent pricing to create a trusted resource for consumers. This partnership enables access to on-demand virtual care in as little as 24 hours, with seamless connection to low-cost drugs.

“Consumers need access to high-quality, affordable healthcare,” said Michael Sentz, CEO of CaringWire. “People need actual health care, not just insurance. This relationship unifies critical components to make that a reality,” added Alex Oshmyansky, CEO of Mark Cuban Cost Plus Drug Company.

This partnership supports individuals’ needs with an accessible solution at their fingertips, connecting a fragmented process to create continuity of care. CaringWire and Cost Plus Drugs bring together employer-sponsored benefits with the option to use Cost Plus Drugs as part of their plan, previously only offered to individuals outside of their insurance package.

“This collaboration highlights the strategic innovation we provide our customers as part of an ever-evolving environment, combining best-in-class solutions into an integrated intuitive experience.” said Michael Sentz. With this relationship, employers and their members utilizing CaringWire will have access to all medications available through Cost Plus Drugs within their benefits package with future plans to expand this offering to health plans and health systems.

About Mark Cuban Cost Plus Drug Company 

The Mark Cuban Cost Plus Drug Company, PBC (Cost Plus Drugs), aims to fundamentally change the way the pharmaceutical industry operates. As a public-benefit corporation, its social mission of improving public health is just as important as the bottom line. Cost Plus Drugs transparently charges a standard markup on every drug it sells. The http://costplusdrugs.com/costplusdrugs.com online pharmacy, launched in January 2022, now carries over 1,000 prescription products delivered by mail to thousands of happy customers every day. Cost Plus Drugs is working with health plans, managed-care organizations, pharmacy benefits managers (PBMs) and self-insured employers to bring these same savings to employer-sponsored benefit plans nationwide.

About CaringWire

CaringWire, founded in 2019, is a uniting force in the benefits market with cutting-edge technology and first-class service. We aggregate the most sought-after healthcare and lifestyle solutions. Our clients enhance the member experience by integrating existing benefits with our customized blend of 15+ non-insurance benefits – all conveniently packaged in an easily accessible mobile app and web platform. Helping members navigate care, access affordable options, reduce stress, save time and money.

Share article on social media or email:

Rampart IC Announces Collaboration With Boston Scientific Corporation to Expand Access to Radiation Safety and Orthopedic Protection


“This collaboration will strengthen our mission to increase access to the Rampart solution for those who are on the front lines performing interventional procedures requiring fluoroscopy,” said Tom Livingston, Rampart IC president and CEO.

Rampart IC, a Birmingham-based medical device company specializing in radiation shielding and orthopedic protection, announced a collaborative agreement with Boston Scientific Corporation, a leading medical device manufacturer, to expand access and promote the importance of radiation safety and orthopedic protection solutions to medical professionals. The companies will work together on sales program offerings for physicians who could benefit from the Rampart shielding technology.

Interventional cardiologists spend extended time in catheterization labs and, therefore, rank as the occupation with the highest level of radiation exposure in the world.1 These physicians often face debilitating injuries resulting from the 20-30-pound lead aprons traditionally worn to reduce radiation exposure,2 with nearly half reporting some form of orthopedic injury.3 The Rampart M1128, which is designed for procedures conducted by interventional cardiologists, electrophysiologists, interventional neurologists, and interventional radiologists, is a fully adjustable and portable system equipped with radiation-attenuating panels that have 1mm lead equivalency, creating a wide shielding area, protecting the physician and surrounding medical personnel. The electric device is easily configured and adjusted, allowing for subtle positioning to suit the body shape of the patient.

“We are honored to work with Boston Scientific, a global medical technology leader, to address a significant unmet need through the protection of more cath lab professionals from harmful radiation exposure,” said Tom Livingston, Rampart IC President and CEO. “This collaboration will strengthen our mission to increase access to the Rampart solution for those who are on the front lines performing interventional procedures requiring fluoroscopy.”

The Rampart IC system is already employed by several prominent American healthcare systems and prestigious university medical institutions. In addition, Rampart IC has signed distribution agreements in the Middle East, Asia, Europe and North America, providing its radiation shielding solution to healthcare professionals in 62 countries around the world.

“I’m very excited about the next generation of operators who are going to be able to work in a better environment both from an orthopedic and radiation standpoint,” said Dr. Bob Foster, Rampart IC Founder and Chief Medical Officer. “The 100-year-old solution of heavy aprons will soon become obsolete. Rampart will allow operators to perform at their best by addressing the challenges of wearing heavy lead and minimizing radiation exposure.”

Rampart IC gained ISO 13485 certification in 2021 to facilitate continued growth in the U.S. and international markets. Rampart IC will handle direct sales within the United States, but they are growing their distribution network for international markets.

In addition to its own international growth, Rampart IC has agreements to sell and distribute products in the United States for Fluke Corporation and Mavig GmbH, a leading provider of personal protective equipment used in hospitals and medical practices.

Learn more at rampartic.com.

1. Zakeri F, Hirobe T, Akbari K. Biological effects of the low–dose radiation exposure on interventional cardiologist. International atomic energy agency: Occ Med ( Lond) 2010;60(6): 464-9

2. Orme NM, Rihal CS, Gulati R, et al. Occupational health hazards of working in the interventional laboratory: a multisite case control study of physicians and allied staff. J Am Coll Cardiol 2015; 65: 820-6.

3. Klein LW, Tra Y, Garratt KN, et al. Society for Cardiovascular Angiography and Interventions. Occupational health hazards of interventional cardiologists in the current decade: Results of the 2014 SCAI membership survey. Catheter Cardiovasc Interv. 2015 Nov; 86(5):913-24.

Share article on social media or email: